Prediction of respiratory insufficiency in Guillain-Barré syndrome
Objective Respiratory insufficiency is a frequent and serious complication of the Guillain‐Barré syndrome (GBS). We aimed to develop a simple but accurate model to predict the chance of respiratory insufficiency in the acute stage of the disease based on clinical characteristics available at hospita...
Gespeichert in:
| Veröffentlicht in: | Annals of neurology Jg. 67; H. 6; S. 781 - 787 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.06.2010
Wiley-Liss |
| Schlagworte: | |
| ISSN: | 0364-5134, 1531-8249, 1531-8249 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Objective
Respiratory insufficiency is a frequent and serious complication of the Guillain‐Barré syndrome (GBS). We aimed to develop a simple but accurate model to predict the chance of respiratory insufficiency in the acute stage of the disease based on clinical characteristics available at hospital admission.
Methods
Mechanical ventilation (MV) in the first week of admission was used as an indicator of acute stage respiratory insufficiency. Prospectively collected data from a derivation cohort of 397 GBS patients were used to identify predictors of MV. A multivariate logistic regression model was validated in a separate cohort of 191 GBS patients. Model performance criteria comprised discrimination (area under receiver operating curve [AUC]) and calibration (graphically). A scoring system for clinical practice was constructed from the regression coefficients of the model in the combined cohorts.
Results
In the derivation cohort, 22% needed MV in the first week of admission. Days between onset of weakness and admission, Medical Research Council sum score, and presence of facial and/or bulbar weakness were the main predictors of MV. The prognostic model had a good discriminative ability (AUC, 0.84). In the validation cohort, 14% needed MV in the first week of admission, and both calibration and discriminative ability of the model were good (AUC, 0.82). The scoring system ranged from 0 to 7, with corresponding chances of respiratory insufficiency from 1 to 91%.
Interpretation
This model accurately predicts development of respiratory insufficiency within 1 week in patients with GBS, using clinical characteristics available at admission. After further validation, the model may assist in clinical decision making, for example, on patient transfer to an intensive care unit. ANN NEUROL 2010;67:781–787 |
|---|---|
| AbstractList | Objective
Respiratory insufficiency is a frequent and serious complication of the Guillain‐Barré syndrome (GBS). We aimed to develop a simple but accurate model to predict the chance of respiratory insufficiency in the acute stage of the disease based on clinical characteristics available at hospital admission.
Methods
Mechanical ventilation (MV) in the first week of admission was used as an indicator of acute stage respiratory insufficiency. Prospectively collected data from a derivation cohort of 397 GBS patients were used to identify predictors of MV. A multivariate logistic regression model was validated in a separate cohort of 191 GBS patients. Model performance criteria comprised discrimination (area under receiver operating curve [AUC]) and calibration (graphically). A scoring system for clinical practice was constructed from the regression coefficients of the model in the combined cohorts.
Results
In the derivation cohort, 22% needed MV in the first week of admission. Days between onset of weakness and admission, Medical Research Council sum score, and presence of facial and/or bulbar weakness were the main predictors of MV. The prognostic model had a good discriminative ability (AUC, 0.84). In the validation cohort, 14% needed MV in the first week of admission, and both calibration and discriminative ability of the model were good (AUC, 0.82). The scoring system ranged from 0 to 7, with corresponding chances of respiratory insufficiency from 1 to 91%.
Interpretation
This model accurately predicts development of respiratory insufficiency within 1 week in patients with GBS, using clinical characteristics available at admission. After further validation, the model may assist in clinical decision making, for example, on patient transfer to an intensive care unit. ANN NEUROL 2010;67:781–787 Respiratory insufficiency is a frequent and serious complication of the Guillain-Barré syndrome (GBS). We aimed to develop a simple but accurate model to predict the chance of respiratory insufficiency in the acute stage of the disease based on clinical characteristics available at hospital admission. Mechanical ventilation (MV) in the first week of admission was used as an indicator of acute stage respiratory insufficiency. Prospectively collected data from a derivation cohort of 397 GBS patients were used to identify predictors of MV. A multivariate logistic regression model was validated in a separate cohort of 191 GBS patients. Model performance criteria comprised discrimination (area under receiver operating curve [AUC]) and calibration (graphically). A scoring system for clinical practice was constructed from the regression coefficients of the model in the combined cohorts. In the derivation cohort, 22% needed MV in the first week of admission. Days between onset of weakness and admission, Medical Research Council sum score, and presence of facial and/or bulbar weakness were the main predictors of MV. The prognostic model had a good discriminative ability (AUC, 0.84). In the validation cohort, 14% needed MV in the first week of admission, and both calibration and discriminative ability of the model were good (AUC, 0.82). The scoring system ranged from 0 to 7, with corresponding chances of respiratory insufficiency from 1 to 91%. This model accurately predicts development of respiratory insufficiency within 1 week in patients with GBS, using clinical characteristics available at admission. After further validation, the model may assist in clinical decision making, for example, on patient transfer to an intensive care unit. Objective Respiratory insufficiency is a frequent and serious complication of the Guillain-Barre syndrome (GBS). We aimed to develop a simple but accurate model to predict the chance of respiratory insufficiency in the acute stage of the disease based on clinical characteristics available at hospital admission. Methods Mechanical ventilation (MV) in the first week of admission was used as an indicator of acute stage respiratory insufficiency. Prospectively collected data from a derivation cohort of 397 GBS patients were used to identify predictors of MV. A multivariate logistic regression model was validated in a separate cohort of 191 GBS patients. Model performance criteria comprised discrimination (area under receiver operating curve [AUC]) and calibration (graphically). A scoring system for clinical practice was constructed from the regression coefficients of the model in the combined cohorts. Results In the derivation cohort, 22% needed MV in the first week of admission. Days between onset of weakness and admission, Medical Research Council sum score, and presence of facial and/or bulbar weakness were the main predictors of MV. The prognostic model had a good discriminative ability (AUC, 0.84). In the validation cohort, 14% needed MV in the first week of admission, and both calibration and discriminative ability of the model were good (AUC, 0.82). The scoring system ranged from 0 to 7, with corresponding chances of respiratory insufficiency from 1 to 91%. Interpretation This model accurately predicts development of respiratory insufficiency within 1 week in patients with GBS, using clinical characteristics available at admission. After further validation, the model may assist in clinical decision making, for example, on patient transfer to an intensive care unit. ANN NEUROL 2010; 67:781-787. Respiratory insufficiency is a frequent and serious complication of the Guillain-Barré syndrome (GBS). We aimed to develop a simple but accurate model to predict the chance of respiratory insufficiency in the acute stage of the disease based on clinical characteristics available at hospital admission.OBJECTIVERespiratory insufficiency is a frequent and serious complication of the Guillain-Barré syndrome (GBS). We aimed to develop a simple but accurate model to predict the chance of respiratory insufficiency in the acute stage of the disease based on clinical characteristics available at hospital admission.Mechanical ventilation (MV) in the first week of admission was used as an indicator of acute stage respiratory insufficiency. Prospectively collected data from a derivation cohort of 397 GBS patients were used to identify predictors of MV. A multivariate logistic regression model was validated in a separate cohort of 191 GBS patients. Model performance criteria comprised discrimination (area under receiver operating curve [AUC]) and calibration (graphically). A scoring system for clinical practice was constructed from the regression coefficients of the model in the combined cohorts.METHODSMechanical ventilation (MV) in the first week of admission was used as an indicator of acute stage respiratory insufficiency. Prospectively collected data from a derivation cohort of 397 GBS patients were used to identify predictors of MV. A multivariate logistic regression model was validated in a separate cohort of 191 GBS patients. Model performance criteria comprised discrimination (area under receiver operating curve [AUC]) and calibration (graphically). A scoring system for clinical practice was constructed from the regression coefficients of the model in the combined cohorts.In the derivation cohort, 22% needed MV in the first week of admission. Days between onset of weakness and admission, Medical Research Council sum score, and presence of facial and/or bulbar weakness were the main predictors of MV. The prognostic model had a good discriminative ability (AUC, 0.84). In the validation cohort, 14% needed MV in the first week of admission, and both calibration and discriminative ability of the model were good (AUC, 0.82). The scoring system ranged from 0 to 7, with corresponding chances of respiratory insufficiency from 1 to 91%.RESULTSIn the derivation cohort, 22% needed MV in the first week of admission. Days between onset of weakness and admission, Medical Research Council sum score, and presence of facial and/or bulbar weakness were the main predictors of MV. The prognostic model had a good discriminative ability (AUC, 0.84). In the validation cohort, 14% needed MV in the first week of admission, and both calibration and discriminative ability of the model were good (AUC, 0.82). The scoring system ranged from 0 to 7, with corresponding chances of respiratory insufficiency from 1 to 91%.This model accurately predicts development of respiratory insufficiency within 1 week in patients with GBS, using clinical characteristics available at admission. After further validation, the model may assist in clinical decision making, for example, on patient transfer to an intensive care unit.INTERPRETATIONThis model accurately predicts development of respiratory insufficiency within 1 week in patients with GBS, using clinical characteristics available at admission. After further validation, the model may assist in clinical decision making, for example, on patient transfer to an intensive care unit. |
| Author | Drenthen, Judith van Doorn, Pieter A. Lingsma, Hester F. Walgaard, Christa Jacobs, Bart C. Ruts, Liselotte Steyerberg, Ewout W. van Koningsveld, Rinske Garssen, Marcel J. P. |
| Author_xml | – sequence: 1 givenname: Christa surname: Walgaard fullname: Walgaard, Christa organization: Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands – sequence: 2 givenname: Hester F. surname: Lingsma fullname: Lingsma, Hester F. organization: Department of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands – sequence: 3 givenname: Liselotte surname: Ruts fullname: Ruts, Liselotte organization: Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands – sequence: 4 givenname: Judith surname: Drenthen fullname: Drenthen, Judith organization: Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands – sequence: 5 givenname: Rinske surname: van Koningsveld fullname: van Koningsveld, Rinske organization: Department of Neurology, Elkerliek Ziekenhuis, Helmond, the Netherlands – sequence: 6 givenname: Marcel J. P. surname: Garssen fullname: Garssen, Marcel J. P. organization: Department of Neurology, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, the Netherlands – sequence: 7 givenname: Pieter A. surname: van Doorn fullname: van Doorn, Pieter A. organization: Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands – sequence: 8 givenname: Ewout W. surname: Steyerberg fullname: Steyerberg, Ewout W. organization: Department of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands – sequence: 9 givenname: Bart C. surname: Jacobs fullname: Jacobs, Bart C. email: b.jacobs@erasmusmc.nl organization: Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22868569$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20517939$$D View this record in MEDLINE/PubMed |
| BookMark | eNqF0c9uEzEQBnCrKmrT0gMvgPaCEIdtx_93j2kEAam0gGh7tBzvWDJsvMHeFeSReA5ejA1JqIRAnKyRft_Imu-EHMYuIiFPKJxTAHZhoz1ntNbqgEyo5LSsmKgPyQS4EqWkXByTk5w_AUCtKByRYwaS6prXEzJ7l7AJrg9dLDpfJMyrkGzfpXURYh68Dy5gdJupmA-hbW2I5aVN6cf3Iq9jk7olPiaPvG0znu3eU3L76uXH2evy6mb-Zja9Kp2oQZXagxIe0VbKaeGd984pqLVsPF1I1JX2yOhCARXCugaks6oSVArJGtY0yE_J8-3eVeq-DJh7swzZ4finiN2QjR6ppMDq_0vOKVOqglE-3clhscTGrFJY2rQ2-wuN4NkO2Oxs65ONLuQHxypVSbVxF1vnUpdzQm9c6O3mrn2yoTUUzKYrM3ZlfnU1Jl78kdgv_Zvdbf8aWlz_G5rp9XSfKLeJkHv89jth02ejNNfS3F_PzR2X7-n87aX5wH8CxzKx5Q |
| CODEN | ANNED3 |
| CitedBy_id | crossref_primary_10_1016_j_jns_2016_08_014 crossref_primary_10_1002_acn3_51984 crossref_primary_10_1097_MS9_0000000000000236 crossref_primary_10_1016_j_nrleng_2023_12_004 crossref_primary_10_1080_14712598_2018_1468885 crossref_primary_10_1016_j_nrleng_2018_03_020 crossref_primary_10_1111_acem_14861 crossref_primary_10_1002_acn3_51627 crossref_primary_10_1186_s13054_015_1037_z crossref_primary_10_1111_jns_12292 crossref_primary_10_1080_14737175_2023_2273386 crossref_primary_10_1212_WNL_0000000000013139 crossref_primary_10_1111_jns_12296 crossref_primary_10_1155_2017_8424198 crossref_primary_10_1111_ene_16073 crossref_primary_10_1586_1744666X_2016_1128829 crossref_primary_10_1016_j_heliyon_2024_e30524 crossref_primary_10_1016_j_spen_2024_101123 crossref_primary_10_1007_s00455_016_9750_6 crossref_primary_10_1111_dmcn_15418 crossref_primary_10_7861_clinmedicine_14_1_72 crossref_primary_10_1111_jns_12209 crossref_primary_10_1007_s12028_019_00769_6 crossref_primary_10_1111_jns_12320 crossref_primary_10_1097_j_pain_0000000000000539 crossref_primary_10_3389_fneur_2024_1385945 crossref_primary_10_5005_jp_journals_10071_24928 crossref_primary_10_1002_brb3_70257 crossref_primary_10_1111_jns_12206 crossref_primary_10_1136_jnnp_2017_316930 crossref_primary_10_1186_cc10305 crossref_primary_10_1016_j_micinf_2022_104954 crossref_primary_10_1097_MAJ_0b013e31820e7ed9 crossref_primary_10_1038_s41572_024_00580_4 crossref_primary_10_1111_ene_16231 crossref_primary_10_1186_s13052_025_02037_0 crossref_primary_10_1016_j_lpm_2019_03_016 crossref_primary_10_1016_j_bjae_2025_05_001 crossref_primary_10_1038_s41582_021_00467_y crossref_primary_10_1002_mus_26706 crossref_primary_10_1007_s12028_020_00965_9 crossref_primary_10_1155_2014_432109 crossref_primary_10_3389_fneur_2022_853469 crossref_primary_10_1212_CON_0000000000001004 crossref_primary_10_1111_j_1600_0404_2011_01503_x crossref_primary_10_1007_s00415_020_10124_x crossref_primary_10_3109_00207454_2016_1163551 crossref_primary_10_1007_s10072_022_06070_3 crossref_primary_10_1097_MD_0000000000038890 crossref_primary_10_2147_JIR_S471626 crossref_primary_10_1111_jns_12673 crossref_primary_10_1111_ane_13294 crossref_primary_10_1186_s12883_024_03899_3 crossref_primary_10_1212_NXI_0000000000000952 crossref_primary_10_1055_s_0043_1777767 crossref_primary_10_1007_s13311_022_01253_4 crossref_primary_10_1016_j_autrev_2016_09_022 crossref_primary_10_1016_j_cger_2021_01_005 crossref_primary_10_1016_j_ncl_2025_05_011 crossref_primary_10_1177_19418744251350831 crossref_primary_10_1111_ene_14742 crossref_primary_10_1111_ene_16365 crossref_primary_10_3389_fneur_2021_746389 crossref_primary_10_1007_s12028_021_01218_z crossref_primary_10_1038_s41591_021_01556_7 crossref_primary_10_1515_revneuro_2023_0024 crossref_primary_10_1007_s10072_023_06784_y crossref_primary_10_1002_acn3_706 crossref_primary_10_1111_ene_16090 crossref_primary_10_1097_WCO_0000000000000602 crossref_primary_10_1111_jns_12661 crossref_primary_10_1017_cjn_2022_19 crossref_primary_10_4103_0028_3886_310063 crossref_primary_10_1016_j_cegh_2019_08_007 crossref_primary_10_1007_s12028_022_01457_8 crossref_primary_10_1089_vim_2021_0187 crossref_primary_10_7759_cureus_48703 crossref_primary_10_1007_s40120_025_00830_x crossref_primary_10_1007_s10072_021_05251_w crossref_primary_10_1111_j_1529_8027_2011_00304_x crossref_primary_10_1016_j_lpm_2013_02_328 crossref_primary_10_1212_CON_0000000000001424 crossref_primary_10_1038_s41582_019_0250_9 crossref_primary_10_1007_s12028_023_01707_3 crossref_primary_10_1016_j_revmed_2021_12_005 crossref_primary_10_1136_jnnp_2022_329937 crossref_primary_10_4187_respcare_08362 crossref_primary_10_1055_s_0044_1785509 crossref_primary_10_1016_j_nrleng_2014_09_003 crossref_primary_10_1016_j_nrl_2018_03_021 crossref_primary_10_1186_s13613_025_01464_w crossref_primary_10_1038_nrneurol_2015_192 crossref_primary_10_1055_s_0043_1778638 crossref_primary_10_1212_CPJ_0b013e31823c85c2 crossref_primary_10_1136_bmjopen_2012_000893 crossref_primary_10_3233_JND_200581 crossref_primary_10_1007_s13760_025_02816_w crossref_primary_10_1080_1744666X_2021_1840355 crossref_primary_10_1016_j_mayocp_2016_12_002 crossref_primary_10_1212_CON_0000000000001438 crossref_primary_10_1016_j_pedneo_2012_07_003 crossref_primary_10_1016_S0140_6736_16_00339_1 crossref_primary_10_1016_S0001_4079_19_30653_3 crossref_primary_10_1055_s_0043_1775750 crossref_primary_10_3389_fimmu_2022_1038411 crossref_primary_10_1016_j_jcrc_2013_10_026 crossref_primary_10_1016_j_jocn_2020_01_032 crossref_primary_10_1136_jnnp_2020_324230 crossref_primary_10_1007_s10072_021_05420_x crossref_primary_10_1111_jns5_12020 crossref_primary_10_5694_mja17_00552 crossref_primary_10_1038_s41598_021_91132_3 crossref_primary_10_1111_ene_15504 crossref_primary_10_1007_s40120_023_00546_w crossref_primary_10_1186_s41983_023_00646_2 crossref_primary_10_1016_j_ajem_2023_10_036 crossref_primary_10_1155_2018_1576927 crossref_primary_10_1177_0883073820978020 crossref_primary_10_7759_cureus_71683 crossref_primary_10_1016_j_neurol_2016_10_011 crossref_primary_10_7759_cureus_19260 crossref_primary_10_1016_j_jocn_2021_07_060 crossref_primary_10_1371_journal_pone_0143837 crossref_primary_10_1002_ana_24908 crossref_primary_10_1002_mus_26905 crossref_primary_10_1016_j_je_2016_07_003 crossref_primary_10_1002_mus_23752 crossref_primary_10_3389_fneur_2024_1368706 crossref_primary_10_1212_CON_0000000000001289 crossref_primary_10_24953_turkjpediatr_2024_4658 crossref_primary_10_1177_1534734619896462 crossref_primary_10_1016_j_neuarg_2025_06_006 crossref_primary_10_1093_cid_cir082 crossref_primary_10_1016_S0140_6736_21_00517_1 crossref_primary_10_1007_s00408_016_9929_5 crossref_primary_10_1007_s13760_020_01421_3 crossref_primary_10_2196_25658 crossref_primary_10_1038_s41572_018_0027_2 crossref_primary_10_1212_CON_0000000000000929 crossref_primary_10_1111_jns_12234 crossref_primary_10_1111_jns_12597 crossref_primary_10_1002_brb3_1496 crossref_primary_10_1080_00207454_2022_2082963 crossref_primary_10_1097_CCM_0000000000006417 crossref_primary_10_1080_14737175_2023_2212163 crossref_primary_10_1111_jns_12594 crossref_primary_10_1016_j_cnp_2025_02_009 crossref_primary_10_1016_j_clineuro_2023_108026 crossref_primary_10_3389_fped_2022_838927 crossref_primary_10_1136_jnnp_2020_323899 crossref_primary_10_1002_mus_26377 crossref_primary_10_1016_j_ejpn_2023_02_007 crossref_primary_10_1016_j_ncl_2017_06_007 crossref_primary_10_1016_j_mcna_2024_09_007 crossref_primary_10_1002_ana_26312 crossref_primary_10_1093_brain_aww247 crossref_primary_10_1002_brb3_611 crossref_primary_10_1186_cc10043 crossref_primary_10_3390_medicina59071267 crossref_primary_10_1111_jpc_13709 crossref_primary_10_7717_peerj_12930 crossref_primary_10_7759_cureus_29047 crossref_primary_10_1007_s12028_011_9536_5 crossref_primary_10_1136_jnnp_2025_336046 crossref_primary_10_3389_fneur_2022_972367 crossref_primary_10_7759_cureus_12101 crossref_primary_10_1016_j_emc_2016_06_006 crossref_primary_10_1097_CND_0000000000000365 crossref_primary_10_1017_cjn_2023_23 crossref_primary_10_1517_14728214_2011_531699 crossref_primary_10_1016_j_jns_2024_123140 crossref_primary_10_1038_nrneurol_2014_121 crossref_primary_10_1007_s40495_023_00334_y crossref_primary_10_1111_ane_12786 crossref_primary_10_1056_NEJMra1114525 crossref_primary_10_1017_cjn_2022_288 crossref_primary_10_1016_j_ejpn_2023_04_003 crossref_primary_10_1016_j_mayocp_2023_08_030 |
| Cites_doi | 10.1016/S0140-6736(05)67665-9 10.1136/jnnp.51.5.605 10.1002/mus.880141111 10.1136/jnnp.64.1.74 10.1093/brain/119.6.2053 10.1097/00000441-200406000-00007 10.1212/01.WNL.0000113718.27729.43 10.1046/j.1468-1331.2003.00505.x 10.1111/j.1600-0404.2008.01107.x 10.1016/S1474-4422(08)70215-1 10.1001/archneur.58.6.893 10.1007/s00134-006-0332-1 10.1002/ana.410350618 10.1212/WNL.35.11.1662 10.1212/WNL.54.12.2311 10.1097/CND.0b013e3181850691 10.1056/NEJM199204233261705 10.1016/S0140-6736(03)15324-X 10.1136/jnnp.2006.102731 10.1016/S1474-4422(07)70130-8 10.1097/00003246-200301000-00044 10.1002/ana.410440512 10.1034/j.1600-0404.2003.00103.x 10.1136/jnnp.2008.154351 10.1212/WNL.47.3.668 10.1002/ana.410270707 10.1212/01.WNL.0000035640.84053.5B 10.1016/S1474-4422(06)70603-2 10.1001/archneur.60.7.947 10.1016/S0140-6736(78)92644-2 10.1016/j.jns.2007.08.005 |
| ContentType | Journal Article |
| Copyright | Copyright © 2010 American Neurological Association 2015 INIST-CNRS |
| Copyright_xml | – notice: Copyright © 2010 American Neurological Association – notice: 2015 INIST-CNRS |
| DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 7TK |
| DOI | 10.1002/ana.21976 |
| DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Neurosciences Abstracts |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Neurosciences Abstracts |
| DatabaseTitleList | MEDLINE Neurosciences Abstracts MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1531-8249 |
| EndPage | 787 |
| ExternalDocumentID | 20517939 22868569 10_1002_ana_21976 ANA21976 ark_67375_WNG_V35Q1GMB_R |
| Genre | article Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: Dutch Prinses Beatrix Fonds funderid: PBF WAR07‐28 – fundername: Clinical Fellowship grant from the Netherlands organization for health research and development funderid: ZonMW 907‐00‐111 |
| GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1CY 1L6 1OB 1OC 1ZS 23M 2QL 31~ 33P 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 66C 6J9 6P2 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEJM AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANHP AANLZ AAONW AAQQT AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABIVO ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBMB ACBWZ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEFGJ AEGXH AEIGN AEIMD AENEX AEUYR AEYWJ AFAZI AFBPY AFFNX AFFPM AFGKR AFRAH AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHMBA AI. AIACR AIAGR AIDQK AIDYY AIQQE AITYG AIURR AJJEV ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRMAN DRSTM EBS EJD EMOBN F00 F01 F04 F5P F8P FEDTE FUBAC FYBCS G-S G.N GNP GODZA GOZPB GRPMH H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M J5H JPC KBYEO KD1 KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LXL LXN LXY LYRES M6M MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NF~ NNB O66 O9- OHT OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.- Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RX1 SAMSI SJN SUPJJ TEORI UB1 V2E V8K V9Y VH1 W8V W99 WBKPD WH7 WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WVDHM WXI WXSBR X7M XG1 XJT XPP XSW XV2 YOC YQJ ZGI ZRF ZRR ZXP ZZTAW ~IA ~WT ~X8 AAYXX CITATION O8X IQODW CGR CUY CVF ECM EIF NPM 7X8 7TK |
| ID | FETCH-LOGICAL-c4906-7f064feea86c74fcffcc60975df1b5e787fe21b60144acd05ca68415452d2dde3 |
| IEDL.DBID | DRFUL |
| ISICitedReferencesCount | 200 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000278208400012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0364-5134 1531-8249 |
| IngestDate | Wed Oct 01 13:20:51 EDT 2025 Fri Sep 05 12:18:29 EDT 2025 Mon Jul 21 05:39:13 EDT 2025 Mon Jul 21 09:14:50 EDT 2025 Sat Nov 29 03:41:16 EST 2025 Tue Nov 18 21:52:53 EST 2025 Wed Aug 20 07:27:21 EDT 2025 Sun Sep 21 06:30:35 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Nervous system diseases Peripheral nerve disease Guillain-Barré syndrome Prediction Inflammatory disease |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4906-7f064feea86c74fcffcc60975df1b5e787fe21b60144acd05ca68415452d2dde3 |
| Notes | Clinical Fellowship grant from the Netherlands organization for health research and development - No. ZonMW 907-00-111 ArticleID:ANA21976 Dutch Prinses Beatrix Fonds - No. PBF WAR07-28 ark:/67375/WNG-V35Q1GMB-R istex:CB16C97022CEEB479BF60CE5BD2CCF9C7EB526C0 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 20517939 |
| PQID | 733126680 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_754551029 proquest_miscellaneous_733126680 pubmed_primary_20517939 pascalfrancis_primary_22868569 crossref_citationtrail_10_1002_ana_21976 crossref_primary_10_1002_ana_21976 wiley_primary_10_1002_ana_21976_ANA21976 istex_primary_ark_67375_WNG_V35Q1GMB_R |
| PublicationCentury | 2000 |
| PublicationDate | June 2010 |
| PublicationDateYYYYMMDD | 2010-06-01 |
| PublicationDate_xml | – month: 06 year: 2010 text: June 2010 |
| PublicationDecade | 2010 |
| PublicationPlace | Hoboken |
| PublicationPlace_xml | – name: Hoboken – name: Hoboken, NJ – name: United States |
| PublicationTitle | Annals of neurology |
| PublicationTitleAlternate | Ann Neurol |
| PublicationYear | 2010 |
| Publisher | Wiley Subscription Services, Inc., A Wiley Company Wiley-Liss |
| Publisher_xml | – name: Wiley Subscription Services, Inc., A Wiley Company – name: Wiley-Liss |
| References | Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet 2005; 366: 1653-1666. Sharshar T, Chevret S, Bourdain F, Raphael JC. Early predictors of mechanical ventilation in Guillain-Barré syndrome. Crit Care Med 2003; 31: 278-283. The Italian Guillain-Barré Study Group. The prognosis and main prognostic indicators of Guillain-Barré syndrome. A multicentre prospective study of 297 patients. Brain 1996; 119 ( pt 6): 2053-2061. Kleyweg RP, van der Meche FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 1991; 14: 1103-1109. Durand MC, Lofaso F, Lefaucheur JP, et al. Electrophysiology to predict mechanical ventilation in Guillain-Barré syndrome. Eur J Neurol 2003; 10: 39-44. van Koningsveld R, Steyerberg EW, Hughes RA, et al. A clinical prognostic scoring system for Guillain-Barré syndrome. Lancet Neurol 2007; 6: 589-594. Visser LH, van der Meche FG, Meulstee J, et al. Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group. Neurology 1996; 47: 668-673. van Koningsveld R, Schmitz PI, Meche FG, et al. Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial. Lancet 2004; 363: 192-196. Steyerberg EW. Clinical prediction models. 1st ed. New York, NY: Springer-Verlag, 2008. Ropper AH, Kehne SM. Guillain-Barré syndrome: management of respiratory failure. Neurology 1985; 35: 1662-1665. Orlikowski D, Sharshar T, Porcher R, et al. Prognosis and risk factors of early onset pneumonia in ventilated patients with Guillain-Barré syndrome. Intensive Care Med 2006; 32: 1962-1969. Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet 1978; 2: 750-753. Garssen MP, van Koningsveld R, van Doorn PA, et al. Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study. J Neurol Neurosurg Psychiatry 2007; 78: 1012-1013. Funakoshi K, Kuwabara S, Odaka M, et al. Clinical predictors of mechanical ventilation in Fisher/Guillain-Barré overlap syndrome. J Neurol Neurosurg Psychiatry 2009; 80: 60-64. Hadden RD, Cornblath DR, Hughes RA, et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol 1998; 44: 780-788. Dourado ME, Duarte RC, Ferreira LC, et al. Anti-ganglioside antibodies and clinical outcome of patients with Guillain-Barré syndrome in northeast Brazil. Acta Neurol Scand 2003; 108: 102-108. Rees JH, Thompson RD, Smeeton NC, Hughes RA. Epidemiological study of Guillain-Barré syndrome in south east England. J Neurol Neurosurg Psychiatry 1998; 64: 74-77. Winer JB, Hughes RA, Osmond C. A prospective study of acute idiopathic neuropathy: I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry 1988; 51: 605-612. Dhar R, Stitt L, Hahn AF. The morbidity and outcome of patients with Guillain-Barré syndrome admitted to the intensive care unit. J Neurol Sci 2008; 264: 121-128. van der Meche FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. N Engl J Med 1992; 326: 1123-1129. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27( suppl): S21-S24. Wijdicks EF, Henderson RD, McClelland RL. Emergency intubation for respiratory failure in Guillain-Barré syndrome. Arch Neurol 2003; 60: 947-948. Orlikowski D, Terzi N, Blumen M, et al. Tongue weakness is associated with respiratory failure in patients with severe Guillain-Barré syndrome. Acta Neurol Scand 2009; 119: 364-370. Lawn ND, Fletcher DD, Henderson RD, et al. Anticipating mechanical ventilation in Guillain-Barré syndrome. Arch Neurol 2001; 58: 893-898. van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol 2008; 7: 939-950. Durand MC, Porcher R, Orlikowski D, et al. Clinical and electrophysiological predictors of respiratory failure in Guillain-Barré syndrome: a prospective study. Lancet Neurol 2006; 5: 1021-1028. Henderson RD, Lawn ND, Fletcher DD, et al. The morbidity of Guillain-Barré syndrome admitted to the intensive care unit. Neurology 2003; 60: 17-21. Fletcher DD, Lawn ND, Wolter TD, Wijdicks EF. Long-term outcome in patients with Guillain-Barré syndrome requiring mechanical ventilation. Neurology 2000; 54: 2311-2315. Cheng BC, Chang WN, Chang CS, et al. Predictive factors and long-term outcome of respiratory failure after Guillain-Barré syndrome. Am J Med Sci 2004; 327: 336-340. Kaida K, Kusunoki S, Kanzaki M, et al. Anti-GQ1b antibody as a factor predictive of mechanical ventilation in Guillain-Barré syndrome. Neurology 2004; 62: 821-824. Souayah N, Nasar A, Suri MF, Qureshi AI. National trends in hospital outcomes among patients with Guillain-Barré syndrome requiring mechanical ventilation. J Clin Neuromuscul Dis 2008; 10: 24-28. The Dutch Guillain-Barré Study Group. Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. Ann Neurol 1994; 35: 749-752. 2004; 363 2004; 62 1991; 14 2009; 80 2006; 32 1992; 326 2008 2006; 5 1978; 2 2008; 7 2008; 10 1988; 51 2009; 119 2008; 264 2004; 327 1998; 64 2007; 78 2003; 31 2003; 10 1998; 44 2003; 108 1990; 27 2005; 366 2000; 54 2007; 6 1994; 35 2003; 60 1996; 47 2001; 58 1996; 119 1985; 35 e_1_2_7_5_2 e_1_2_7_4_2 e_1_2_7_3_2 e_1_2_7_2_2 e_1_2_7_9_2 e_1_2_7_8_2 e_1_2_7_7_2 e_1_2_7_6_2 e_1_2_7_18_2 e_1_2_7_17_2 e_1_2_7_16_2 e_1_2_7_15_2 e_1_2_7_14_2 e_1_2_7_13_2 e_1_2_7_12_2 e_1_2_7_11_2 e_1_2_7_10_2 e_1_2_7_26_2 e_1_2_7_27_2 e_1_2_7_29_2 The Italian Guillain‐Barré Study Group (e_1_2_7_19_2) 1996; 119 Steyerberg EW (e_1_2_7_28_2) 2008 e_1_2_7_25_2 e_1_2_7_24_2 e_1_2_7_30_2 e_1_2_7_23_2 e_1_2_7_31_2 e_1_2_7_22_2 e_1_2_7_32_2 e_1_2_7_21_2 e_1_2_7_33_2 e_1_2_7_20_2 |
| References_xml | – reference: The Italian Guillain-Barré Study Group. The prognosis and main prognostic indicators of Guillain-Barré syndrome. A multicentre prospective study of 297 patients. Brain 1996; 119 ( pt 6): 2053-2061. – reference: van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol 2008; 7: 939-950. – reference: Winer JB, Hughes RA, Osmond C. A prospective study of acute idiopathic neuropathy: I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry 1988; 51: 605-612. – reference: van der Meche FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. N Engl J Med 1992; 326: 1123-1129. – reference: Dourado ME, Duarte RC, Ferreira LC, et al. Anti-ganglioside antibodies and clinical outcome of patients with Guillain-Barré syndrome in northeast Brazil. Acta Neurol Scand 2003; 108: 102-108. – reference: Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet 2005; 366: 1653-1666. – reference: Garssen MP, van Koningsveld R, van Doorn PA, et al. Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study. J Neurol Neurosurg Psychiatry 2007; 78: 1012-1013. – reference: Sharshar T, Chevret S, Bourdain F, Raphael JC. Early predictors of mechanical ventilation in Guillain-Barré syndrome. Crit Care Med 2003; 31: 278-283. – reference: Fletcher DD, Lawn ND, Wolter TD, Wijdicks EF. Long-term outcome in patients with Guillain-Barré syndrome requiring mechanical ventilation. Neurology 2000; 54: 2311-2315. – reference: Durand MC, Porcher R, Orlikowski D, et al. Clinical and electrophysiological predictors of respiratory failure in Guillain-Barré syndrome: a prospective study. Lancet Neurol 2006; 5: 1021-1028. – reference: Dhar R, Stitt L, Hahn AF. The morbidity and outcome of patients with Guillain-Barré syndrome admitted to the intensive care unit. J Neurol Sci 2008; 264: 121-128. – reference: Funakoshi K, Kuwabara S, Odaka M, et al. Clinical predictors of mechanical ventilation in Fisher/Guillain-Barré overlap syndrome. J Neurol Neurosurg Psychiatry 2009; 80: 60-64. – reference: Rees JH, Thompson RD, Smeeton NC, Hughes RA. Epidemiological study of Guillain-Barré syndrome in south east England. J Neurol Neurosurg Psychiatry 1998; 64: 74-77. – reference: Wijdicks EF, Henderson RD, McClelland RL. Emergency intubation for respiratory failure in Guillain-Barré syndrome. Arch Neurol 2003; 60: 947-948. – reference: Kaida K, Kusunoki S, Kanzaki M, et al. Anti-GQ1b antibody as a factor predictive of mechanical ventilation in Guillain-Barré syndrome. Neurology 2004; 62: 821-824. – reference: Orlikowski D, Terzi N, Blumen M, et al. Tongue weakness is associated with respiratory failure in patients with severe Guillain-Barré syndrome. Acta Neurol Scand 2009; 119: 364-370. – reference: Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27( suppl): S21-S24. – reference: van Koningsveld R, Steyerberg EW, Hughes RA, et al. A clinical prognostic scoring system for Guillain-Barré syndrome. Lancet Neurol 2007; 6: 589-594. – reference: Visser LH, van der Meche FG, Meulstee J, et al. Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group. Neurology 1996; 47: 668-673. – reference: Steyerberg EW. Clinical prediction models. 1st ed. New York, NY: Springer-Verlag, 2008. – reference: Kleyweg RP, van der Meche FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 1991; 14: 1103-1109. – reference: Lawn ND, Fletcher DD, Henderson RD, et al. Anticipating mechanical ventilation in Guillain-Barré syndrome. Arch Neurol 2001; 58: 893-898. – reference: Souayah N, Nasar A, Suri MF, Qureshi AI. National trends in hospital outcomes among patients with Guillain-Barré syndrome requiring mechanical ventilation. J Clin Neuromuscul Dis 2008; 10: 24-28. – reference: Durand MC, Lofaso F, Lefaucheur JP, et al. Electrophysiology to predict mechanical ventilation in Guillain-Barré syndrome. Eur J Neurol 2003; 10: 39-44. – reference: Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet 1978; 2: 750-753. – reference: van Koningsveld R, Schmitz PI, Meche FG, et al. Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial. Lancet 2004; 363: 192-196. – reference: Ropper AH, Kehne SM. Guillain-Barré syndrome: management of respiratory failure. Neurology 1985; 35: 1662-1665. – reference: Henderson RD, Lawn ND, Fletcher DD, et al. The morbidity of Guillain-Barré syndrome admitted to the intensive care unit. Neurology 2003; 60: 17-21. – reference: Hadden RD, Cornblath DR, Hughes RA, et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol 1998; 44: 780-788. – reference: Cheng BC, Chang WN, Chang CS, et al. Predictive factors and long-term outcome of respiratory failure after Guillain-Barré syndrome. Am J Med Sci 2004; 327: 336-340. – reference: Orlikowski D, Sharshar T, Porcher R, et al. Prognosis and risk factors of early onset pneumonia in ventilated patients with Guillain-Barré syndrome. Intensive Care Med 2006; 32: 1962-1969. – reference: The Dutch Guillain-Barré Study Group. Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. Ann Neurol 1994; 35: 749-752. – volume: 10 start-page: 24 year: 2008 end-page: 28 article-title: National trends in hospital outcomes among patients with Guillain‐Barré syndrome requiring mechanical ventilation publication-title: J Clin Neuromuscul Dis – volume: 27 start-page: S21 issue: suppl year: 1990 end-page: S24 article-title: Assessment of current diagnostic criteria for Guillain‐Barré syndrome publication-title: Ann Neurol – volume: 58 start-page: 893 year: 2001 end-page: 898 article-title: Anticipating mechanical ventilation in Guillain‐Barré syndrome publication-title: Arch Neurol – volume: 108 start-page: 102 year: 2003 end-page: 108 article-title: Anti‐ganglioside antibodies and clinical outcome of patients with Guillain‐Barré syndrome in northeast Brazil publication-title: Acta Neurol Scand – volume: 119 start-page: 364 year: 2009 end-page: 370 article-title: Tongue weakness is associated with respiratory failure in patients with severe Guillain‐Barré syndrome publication-title: Acta Neurol Scand – volume: 5 start-page: 1021 year: 2006 end-page: 1028 article-title: Clinical and electrophysiological predictors of respiratory failure in Guillain‐Barré syndrome: a prospective study publication-title: Lancet Neurol – volume: 363 start-page: 192 year: 2004 end-page: 196 article-title: Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain‐Barré syndrome: randomised trial publication-title: Lancet – volume: 7 start-page: 939 year: 2008 end-page: 950 article-title: Clinical features, pathogenesis, and treatment of Guillain‐Barré syndrome publication-title: Lancet Neurol – volume: 2 start-page: 750 year: 1978 end-page: 753 article-title: Controlled trial prednisolone in acute polyneuropathy publication-title: Lancet – volume: 60 start-page: 947 year: 2003 end-page: 948 article-title: Emergency intubation for respiratory failure in Guillain‐Barré syndrome publication-title: Arch Neurol – volume: 366 start-page: 1653 year: 2005 end-page: 1666 article-title: Guillain‐Barré syndrome publication-title: Lancet – volume: 80 start-page: 60 year: 2009 end-page: 64 article-title: Clinical predictors of mechanical ventilation in Fisher/Guillain‐Barré overlap syndrome publication-title: J Neurol Neurosurg Psychiatry – volume: 10 start-page: 39 year: 2003 end-page: 44 article-title: Electrophysiology to predict mechanical ventilation in Guillain‐Barré syndrome publication-title: Eur J Neurol – volume: 326 start-page: 1123 year: 1992 end-page: 1129 article-title: A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain‐Barré syndrome publication-title: N Engl J Med – volume: 78 start-page: 1012 year: 2007 end-page: 1013 article-title: Treatment of Guillain‐Barré syndrome with mycophenolate mofetil: a pilot study publication-title: J Neurol Neurosurg Psychiatry – volume: 264 start-page: 121 year: 2008 end-page: 128 article-title: The morbidity and outcome of patients with Guillain‐Barré syndrome admitted to the intensive care unit publication-title: J Neurol Sci – volume: 51 start-page: 605 year: 1988 end-page: 612 article-title: A prospective study of acute idiopathic neuropathy: I. Clinical features and their prognostic value publication-title: J Neurol Neurosurg Psychiatry – volume: 31 start-page: 278 year: 2003 end-page: 283 article-title: Early predictors of mechanical ventilation in Guillain‐Barré syndrome publication-title: Crit Care Med – volume: 64 start-page: 74 year: 1998 end-page: 77 article-title: Epidemiological study of Guillain‐Barré syndrome in south east England publication-title: J Neurol Neurosurg Psychiatry – volume: 60 start-page: 17 year: 2003 end-page: 21 article-title: The morbidity of Guillain‐Barré syndrome admitted to the intensive care unit publication-title: Neurology – volume: 32 start-page: 1962 year: 2006 end-page: 1969 article-title: Prognosis and risk factors of early onset pneumonia in ventilated patients with Guillain‐Barré syndrome publication-title: Intensive Care Med – volume: 62 start-page: 821 year: 2004 end-page: 824 article-title: Anti‐GQ1b antibody as a factor predictive of mechanical ventilation in Guillain‐Barré syndrome publication-title: Neurology – volume: 35 start-page: 749 year: 1994 end-page: 752 article-title: Treatment of Guillain‐Barré syndrome with high‐dose immune globulins combined with methylprednisolone: a pilot study publication-title: Ann Neurol – volume: 327 start-page: 336 year: 2004 end-page: 340 article-title: Predictive factors and long‐term outcome of respiratory failure after Guillain‐Barré syndrome publication-title: Am J Med Sci – volume: 6 start-page: 589 year: 2007 end-page: 594 article-title: A clinical prognostic scoring system for Guillain‐Barré syndrome publication-title: Lancet Neurol – volume: 54 start-page: 2311 year: 2000 end-page: 2315 article-title: Long‐term outcome in patients with Guillain‐Barré syndrome requiring mechanical ventilation publication-title: Neurology – volume: 119 start-page: 2053 issue: pt 6 year: 1996 end-page: 2061 article-title: The prognosis and main prognostic indicators of Guillain‐Barré syndrome. A multicentre prospective study of 297 patients publication-title: Brain – volume: 44 start-page: 780 year: 1998 end-page: 788 article-title: Electrophysiological classification of Guillain‐Barré syndrome: clinical associations and outcome publication-title: Ann Neurol – volume: 47 start-page: 668 year: 1996 end-page: 673 article-title: Cytomegalovirus infection and Guillain‐Barré syndrome: the clinical, electrophysiologic, and prognostic features publication-title: Neurology – year: 2008 – volume: 14 start-page: 1103 year: 1991 end-page: 1109 article-title: Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain‐Barré syndrome publication-title: Muscle Nerve – volume: 35 start-page: 1662 year: 1985 end-page: 1665 article-title: Guillain‐Barré syndrome: management of respiratory failure publication-title: Neurology – ident: e_1_2_7_32_2 doi: 10.1016/S0140-6736(05)67665-9 – volume-title: Clinical prediction models year: 2008 ident: e_1_2_7_28_2 – ident: e_1_2_7_5_2 doi: 10.1136/jnnp.51.5.605 – ident: e_1_2_7_26_2 doi: 10.1002/mus.880141111 – ident: e_1_2_7_4_2 doi: 10.1136/jnnp.64.1.74 – volume: 119 start-page: 2053 issue: 6 year: 1996 ident: e_1_2_7_19_2 article-title: The prognosis and main prognostic indicators of Guillain‐Barré syndrome. A multicentre prospective study of 297 patients publication-title: Brain doi: 10.1093/brain/119.6.2053 – ident: e_1_2_7_9_2 doi: 10.1097/00000441-200406000-00007 – ident: e_1_2_7_13_2 doi: 10.1212/01.WNL.0000113718.27729.43 – ident: e_1_2_7_17_2 doi: 10.1046/j.1468-1331.2003.00505.x – ident: e_1_2_7_14_2 doi: 10.1111/j.1600-0404.2008.01107.x – ident: e_1_2_7_31_2 doi: 10.1016/S1474-4422(08)70215-1 – ident: e_1_2_7_6_2 doi: 10.1001/archneur.58.6.893 – ident: e_1_2_7_10_2 doi: 10.1007/s00134-006-0332-1 – ident: e_1_2_7_22_2 doi: 10.1002/ana.410350618 – ident: e_1_2_7_33_2 doi: 10.1212/WNL.35.11.1662 – ident: e_1_2_7_3_2 doi: 10.1212/WNL.54.12.2311 – ident: e_1_2_7_11_2 doi: 10.1097/CND.0b013e3181850691 – ident: e_1_2_7_21_2 doi: 10.1056/NEJM199204233261705 – ident: e_1_2_7_23_2 doi: 10.1016/S0140-6736(03)15324-X – ident: e_1_2_7_25_2 doi: 10.1136/jnnp.2006.102731 – ident: e_1_2_7_20_2 doi: 10.1016/S1474-4422(07)70130-8 – ident: e_1_2_7_15_2 doi: 10.1097/00003246-200301000-00044 – ident: e_1_2_7_29_2 doi: 10.1002/ana.410440512 – ident: e_1_2_7_30_2 doi: 10.1034/j.1600-0404.2003.00103.x – ident: e_1_2_7_16_2 doi: 10.1136/jnnp.2008.154351 – ident: e_1_2_7_18_2 doi: 10.1212/WNL.47.3.668 – ident: e_1_2_7_24_2 doi: 10.1002/ana.410270707 – ident: e_1_2_7_8_2 doi: 10.1212/01.WNL.0000035640.84053.5B – ident: e_1_2_7_12_2 doi: 10.1016/S1474-4422(06)70603-2 – ident: e_1_2_7_7_2 doi: 10.1001/archneur.60.7.947 – ident: e_1_2_7_27_2 doi: 10.1016/S0140-6736(78)92644-2 – ident: e_1_2_7_2_2 doi: 10.1016/j.jns.2007.08.005 |
| SSID | ssj0009610 |
| Score | 2.4529188 |
| Snippet | Objective
Respiratory insufficiency is a frequent and serious complication of the Guillain‐Barré syndrome (GBS). We aimed to develop a simple but accurate... Respiratory insufficiency is a frequent and serious complication of the Guillain-Barré syndrome (GBS). We aimed to develop a simple but accurate model to... Objective Respiratory insufficiency is a frequent and serious complication of the Guillain-Barre syndrome (GBS). We aimed to develop a simple but accurate... |
| SourceID | proquest pubmed pascalfrancis crossref wiley istex |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 781 |
| SubjectTerms | Adult Area Under Curve Biological and medical sciences Cohort Studies Female Guillain-Barre Syndrome - complications Humans Male Medical sciences Middle Aged Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis Neurology Predictive Value of Tests Probability Reproducibility of Results Respiration, Artificial - methods Respiratory Insufficiency - diagnosis Respiratory Insufficiency - etiology Respiratory Insufficiency - rehabilitation Retrospective Studies Risk Factors Severity of Illness Index Young Adult |
| Title | Prediction of respiratory insufficiency in Guillain-Barré syndrome |
| URI | https://api.istex.fr/ark:/67375/WNG-V35Q1GMB-R/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fana.21976 https://www.ncbi.nlm.nih.gov/pubmed/20517939 https://www.proquest.com/docview/733126680 https://www.proquest.com/docview/754551029 |
| Volume | 67 |
| WOSCitedRecordID | wos000278208400012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1531-8249 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009610 issn: 0364-5134 databaseCode: DRFUL dateStart: 19990101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NTtwwEB7BblX1QukPsKWsoqqquKQkduI44rT87PYAK4oK3ZvlOLaEqLIoy6Ie-wh9DZ6DN-mTdOz8rFaiVaXeHGVsyfNjjz3jbwDeS5SrNtSgiWvtRymP_EwZ40eh0nmeqZS4kiyXJ8l4zCeT9GwF9pu3MBU-RHvhZi3DrdfWwGU221uAhspCfkRzS9gqdAnqbdyB7tH58OJkgbnLHBiBjbT5cUijBlgoIHtt56XtqGs5-92mR8oZcshUpS0e8z2XXVm3Fw2f_9cs1mGtdkG9QaUzL2BFFy_h6WkdZH8Fx2elbVuJeVPjlYtgvGcz1x3mhH2wiV_eaG6rFl0Vv378PJBl-XDvNRAIr-FiePzl8JNfV1vwVZQGzE8MeidGa8mZSiKDAlOKBWkS5ybMYo2GbTQJM2aPYFLlQawk45GrUZ4TXCTpBnSKaaG3wGPUKBoaQlNjj2uch5rlEc5SShlQSXuw2zBdqBqK3FbE-CYqEGUikC3CsaUH71rSmwp_4zGiD05yLYUsr23CWhKLr-ORuKTx53B0eiDOe9BfEm3bgRDOeMzSHniNrAXamQ2eyEJP5zNha1uiM8ODv5AgL3CJIzjKZqUmi_EdFBrFP7tOG_48FzEYD1zjzb-TbsOzKqnBXg69hc5tOdc78ETd3V7Nyj6sJhPer43jN_2YEiU |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwEB6VLgIu_EOXnxIhhHoJTWzHcSQuW-huEbtRqdrSm-V1bKkCZatsF_XYR-A1eA7ehCdh7PysVioIiZujjC15fuyxZ_wNwCuFcjWWWjRxY0KWCRZOtbUhi7UpiqnOiC_JcjxO81ycnGT7a_C2fQtT40N0F27OMvx67QzcXUhvL1FDVaneoL2l_Br0GKoR6nfv_cHwaLwE3eUejcCF2sIkpqxFForIdtd5ZT_qOdZeuPxINUcW2bq2xVXO56ov6zej4Z3_m8ZduN04ocGg1pp7sGbK-3Bj0oTZH8DufuXaTmbBzAbVMhwfuNx1jzrhnmziVzBauLpFp-Wvy-87qqp-_ghaEISHcDTcPXy3Fzb1FkLNsoiHqUX_xBqjBNcpsygyrXmUpUlh42li0LStIfGUu0OY0kWUaMUF81XKC4LLJH0E6-WsNBsQcGo1jS2hmXUHNiFiwwuGs1RKRVTRPmy1XJe6ASN3NTG-yhpGmUhki_Rs6cPLjvSsRuC4iui1F11HoaovLmUtTeTnfCSPafIpHk125EEfNldk23UgRHCR8KwPQStsiZbmwieqNLPFXLrqlujOiOgvJMgLXOQIjvK41pPl-B4MjeKfLa8Of56LHOQD33jy76Qv4Obe4WQsxx_yj0_hVp3i4K6KnsH6ebUwz-G6_nZ-Oq82Gxv5DeP0FS0 |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwEB6VXVRx4R-6_JQIIdRLaGI7jiNx2dLugthGS0VLb5bXsaWKKltlu4gjj8Br8By8CU-Cx_lZrVQQEjdHGVvyjMcee-zvA3ihnF2Npda5uDEhywQLZ9rakMXaFMVMZ8RTspxM0jwXp6fZdANet29hanyI7sANPcPP1-jg5qKwuyvUUFWqV87fUn4N-gxJZHrQ3z8aHU9WoLvcoxFgqi1MYspaZKGI7HaV19ajPqr2K96PVAunIltzW1wVfK7Hsn4xGt36v27chptNEBoM61FzBzZMeRc2D5s0-z04mFZYRpsFcxtUq3R8gHfXPeoEPtl0X8F4ibxFZ-Wvb9_3VFX9_BG0IAj34Xh08PHN27DhWwg1yyIeptbFJ9YYJbhOmXUm05pHWZoUNp4lxrm2NSSecdyEKV1EiVZcMM9SXhA3TdIH0CvnpdmCgFOraWwJzSxu2ISIDS-Y66VSKqKKDmCn1brUDRg5cmKcyxpGmUinFunVMoDnnehFjcBxldBLb7pOQlWf8cpamshP-Vie0ORDPD7ck0cD2F6zbVeBEMFFwrMBBK2xpfM0TJ-o0syXC4nsli6cEdFfRJwu3CRHXCsP63Gyat-DoVH3Z8cPhz_3RQ7zoS88-nfRZ7A53R_Jybv8_WO4Ud9wwJOiJ9C7rJbmKVzXXy7PFtV24yK_AVJtFKg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prediction+of+Respiratory+Insufficiency+in+Guillain-Barr%C3%A9+Syndrome&rft.jtitle=Annals+of+neurology&rft.au=WALGAARD%2C+Christa&rft.au=LINGSMA%2C+Hester+F&rft.au=RUTS%2C+Liselotte&rft.au=DRENTHEN%2C+Judith&rft.date=2010-06-01&rft.pub=Wiley-Liss&rft.issn=0364-5134&rft.volume=67&rft.issue=6&rft.spage=781&rft.epage=787&rft_id=info:doi/10.1002%2Fana.21976&rft.externalDBID=n%2Fa&rft.externalDocID=22868569 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0364-5134&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0364-5134&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0364-5134&client=summon |